anti-GCC ADC (Heidelberg Pharma)

N/A

Report date: 2025/06/11 11:25:06

Base Information

Drug Nameanti-GCC ADC (Heidelberg Pharma)
Drug Alias NameGCC-targeting exatecan antibody drug conjugate (Heidelberg Pharma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionHeat-stable enterotoxin receptor modulatorsDNA topoisomerase I inhibitors
TargetsHeat-stable enterotoxin receptorDNA topoisomerase I
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHeidelberg Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesHeidelberg Pharma AG
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A